| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8466905 | Cytotherapy | 2018 | 14 Pages |
Abstract
The new cost/yield adequate method allows isolation from menstrual blood a relatively homogenous pool of highly proliferative MSCs, which seem to be the best candidates for internal organ therapy due to their proepithelial background (early expression of CK7 and its easy induction in later passages) and for mass cryobanking due to their high yield and availability.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Marina V. Kovina, Michael E. Krasheninnikov, Tatiana G. Dyuzheva, Michael I. Danilevsky, Ilya D. Klabukov, Maxim V. Balyasin, Olga K. Chivilgina, Alexey V. Lyundup,